Literature DB >> 6965232

A specific vaccine effective against stage I and stage II malignant disease in guinea pigs. Effect of variations in preparations and storage.

E Yarkoni1, J T Hunter, S Sukumar.   

Abstract

Guinea pigs, each with an established, syngeneic dermal line 10 tumor and lymph node metastases, were immunized by intradermal injection of a mixture of irradiated line 10 cells and an emulsion containing heat-killed BCG. Immunization eradicated 7- or 10-day-old dermal tumors (about 10 or 12 mm in diameter, respectively) and prevented growth of microscopic lymph node metastases. Fourteen-day-old dermal tumors (about 15 mm in diameter) were not rejected by immunization. Guinea pigs with stage II disease (21-day-old dermal tumors and palpable metastases in the first draining lymph node) were treated by excision of the dermal tumor and the first draining lymph node, and by specific immunization. This treatment eliminated tumor cells remaining in the second draining lymph nodes. The surgical treatment alone was not curative, palpable metastases in the second draining lymph nodes progressed and the animals died (some with visible lung metastases). Emulsions containing killed BCG were good adjuvants even after prolonged storage at 4 degrees C, but lost most of their adjuvant activity after autoclaving or freezing.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6965232     DOI: 10.1007/BF00200174

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  15 in total

Review 1.  A guinea pig model for tumor immunology. A summary.

Authors:  H J Rapp
Journal:  Isr J Med Sci       Date:  1973-03

2.  Eradication by active specific immunotherapy of established tumor transplants and microscopic lymph node metastases.

Authors:  E Yarkoni; M P Ashley; B Zbar; T Sugimoto; H J Rapp
Journal:  Cancer Res       Date:  1982-07       Impact factor: 12.701

3.  Eradication by immunization with mycobacterial vaccines and tumor cells of microscopic metastases remaining after surgery.

Authors:  B Zbar; G Canti; M P Ashley; H J Rapp; J T Hunter; E Ribi
Journal:  Cancer Res       Date:  1979-05       Impact factor: 12.701

4.  Immunotherapy and vaccination against cancer with non-living BCG and cord factor (trehalose-6,6'-dimycolate).

Authors:  A Bekierkunst
Journal:  Int J Cancer       Date:  1975-09-15       Impact factor: 7.396

5.  Adjuvant-antigen requirements for active specific immunotherapy of microscopic metastases remaining after surgery.

Authors:  M P Ashley; B Zbar; J T Hunter; H J Rapp; T Sugimoto
Journal:  Cancer Res       Date:  1980-11       Impact factor: 12.701

6.  Immunotherapy of guinea pigs with a transplanted hepatoma: comparison of intralesionally administered killed BCG cells and BCG cell walls.

Authors:  E Yarkoni; H J Rapp
Journal:  Infect Immun       Date:  1979-09       Impact factor: 3.441

7.  Regression by active specific immunotherapy of established dermal tumor transplants and lymph node metastases in guinea pigs.

Authors:  E Yarkoni; H J Rapp
Journal:  Infect Immun       Date:  1981-01       Impact factor: 3.441

8.  Immunotherapy of experimental cancer by intralesional injection of emulsified nonliving mycobacteria: comparison of Mycobacterium bovis (BCG), Mycobacterium phlei, and Mycobacterium smegmatis.

Authors:  E Yarkoni; H J Rapp
Journal:  Infect Immun       Date:  1980-06       Impact factor: 3.441

9.  Influence of type of oil and surfactant concentration on the efficacy of emulsified Mycobacterium bovis BCG cell walls to induce tumor regression in guinea pigs.

Authors:  E Yarkoni; H J Rapp
Journal:  Infect Immun       Date:  1980-06       Impact factor: 3.441

10.  Treatment by limited surgery and specific immunization of guinea pigs with stage II experimental cancer.

Authors:  J T Hunter; M P Ashley; S Sukumar; T Sugimoto; B Zbar; H J Rapp; E Yarkoni
Journal:  J Exp Med       Date:  1981-08-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.